EMJ Hematology 7.1 2019 – European Medical Journal
EMJ Hematology 7.1 aims to provide you with a detailed review of the event, an account that is perfectly accompanied by a hand-picked selection of…
Related Articles
Hema Now: Episode 8: What’s Next in Lymphoma Diagnosis and Treatment?
Uncover the future of lymphoma care with Marc Hoffman, Professor, Hematologic Malignancies at the University of Kansas Medical Center.
Hema Now: Episode 8: What’s Next in Lymphoma Diagnosis and Treatment?
Uncover the future of lymphoma care with Marc Hoffman, Professor, Hematologic Malignancies at the University of Kansas Medical Center.
CAR-T Cell Therapy Shows Promise for Transformed Indolent Non-Hodgkin Lymphoma
A recent retrospective study has shed new light on the effectiveness of chimeric antigen receptor T cell therapy for patients with transformed indolent non-Hodgkin lymphoma
Blood Pressure Fluctuations Linked to Cognitive Decline in Older Adults
A new study highlights the link between visit-to-visit blood pressure variability (BPV) and cognitive decline in older adults. Read on!
New Metric Offers Insight into Red Blood Cell Function and Quality
A recent study has introduced FlowScore, a new metric for evaluating the quality of red blood cells that goes beyond traditional haemoglobin assays. Read on…
Hema Now: Episode 7: Decoding T Cells and Advancing Immunology
Discover the immunobiology of Myelodysplastic syndrome and Aplastic anaemia, the role of CD4+ T cells in myeloid malignancies, and more. Listen today
Blood-Based Ageing Clock Shows Promise as a Clinical Tool
A groundbreaking study has developed a blood-based ageing clock capable of predicting biological age and providing insights into the ageing process. Read on to learn…
Hema Now: Episode 6: Transforming Stem Cell Transplantation
Discover advancements in stem cell transplantation, the state of haematology in Latin America, and more in this episode. Listen now
Home Time Benefits in Older Leukemia Patients’ Treatments
Read on to discover how time spent at home has shown to impact treatment decision-making in older adults with acute myeloid leukaemia.
Immune Landscape of Multiple Myeloma Uncovered
A ground breaking study mapping the immune microenvironment in Multiple Myeloma identifies critical immune changes and highlights the potential of immune-boosting therapies like αCD40 to…